NCT06655701 Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis
| NCT ID | NCT06655701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beylikduzu State Hospital |
| Condition | Osteoporosis, Postmenopausal |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-11-15 |
| Primary Completion | 2025-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-11-15 with a primary completion date of 2025-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of our study is to evaluate the presence of stress urinary incontinence in postmenopausal patients with and without osteoporosis, determine its impact on quality of life, and explore its relationship with sarcopenia.
Eligibility Criteria
Inclusion Criteria: * Postmenopausal women with DXA measurements performed within the last 6 months. * Based on DXA measurements: Femoral neck and L1-L4 T-scores of -1 and above will be included in the control group (non-osteoporotic). Femoral neck and L1-L4 T-scores of -2.5 and below will be included in the osteoporosis group. * Aged 50-75 years Exclusion Criteria: * Refusal to participate in the study. * History of neurological diseases, infections, surgeries, or trauma that could cause urinary incontinence or muscle loss. * Presence of psychiatric disorders. * Cognitive impairments. * Use of medications that could affect the study results.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06655701 clinical trial?
This trial is open to female participants only, aged 50 Years or older, up to 75 Years, studying Osteoporosis, Postmenopausal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06655701 currently recruiting?
Yes, NCT06655701 is actively recruiting participants. Contact the research team at bsrn080@gmail.com for enrollment information.
Where is the NCT06655701 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06655701 clinical trial?
NCT06655701 is sponsored by Beylikduzu State Hospital. The trial plans to enroll 100 participants.